Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting

Summary

The FDA will host a joint meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to discuss the safety and efficacy of certain medications. The meeting will take place on October 24, 2023, at the FDA White Oak Campus in Silver Spring, Maryland.